Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Global Drug Discovery and Development Solutions Market: By Service Type: Medicinal Chemistry, Biology Services, Others; By Drug Type; By Process; By Technology; By Mode; By Therapeutic Area; By End Use; Regional Analysis; Historical Market and Forecast (2016-2026); Competitive Landscape; Industry Events and Developments
Global Drug Discovery and Development Solutions Market Outlook
The global drug discovery and development solutions market is expected to grow at a CAGR of 13% in the forecast period of 2021-2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America to be a Significant Regional Market for the Drug Discovery and Development Solutions Industry
The global market for drug discovery and development solutions is significantly aided by the industry growth in North America. The development of the drug discovery outsourcing industry in the region could be attributed to an increase in emphasis on discovering medicines for the treatment of COVID-19, which has resulted in drug discovery outsourcing to companies equipped with AI technology. In addition, the growth in the investment in research and development (R&D) by major pharmaceutical and biotechnology firms and their emphasis on streamlining the internal costs of drug discovery outsourcing is fuelling the growth of the drug discovery and development solutions industry.
Drug Discovery and Development Solutions: Industry Definition and Segmentation
Drug discovery refers to the discovery of new medication and to the process of creating a therapeutically active substance for a particular target molecule or pathway. Drug discovery comprises of screening hits, medicinal chemistry, and optimisation of hits to reduce possible side effects of drugs. The discovery and development solutions of drugs together is a full process of identifying and introducing a new medication in the market.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The service types in the market can be divided into the following:
- Medicinal Chemistry
- Biology Services
- Drug Metabolism
- Pharmaceutical Services
- Pharmacokinetics
- Others
The drug types in the market can be divided into small molecules and biologics. The process types can be segmented as:
- Target Selection
- Target Validation
- Hit-To-Lead Identification
- Lead Optimisation
- Candidate Validation
- Others
The technology types in the industry can be segmented into the following:
- High Throughput Screening
- Biochips
- Pharmacogenetics
- Nanotechnology
- Spectroscopy
- Others
Based on therapeutic area, the market can be segmented into:
- Oncology
- Neurology
- Infectious and Immune System Diseases
- Digestive System Diseases
- Cardiovascular Diseases
- Others
The regional markets for drug discovery and development solutions can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rising R&D Activities in the Pharmaceuticals Sector Bolstering the Market Growth for Drug Discovery and Development Solutions
The expansion of the demand for drug discovery outsourcing can be attributed to an increase in the emphasis on discovering medicines for the treatment of the rising COVID-19 pandemic, which has resulted in drug discovery outsourcing to companies equipped with AI technology. In addition, the growth in the investment in research and development (R&D) by major pharmaceutical and biotechnology firms and their emphasis on streamlining the internal costs of drug discovery outsourcing is fuelling the market growth. Developments in fundamental algorithms are used in computational information processing for predictive chemistry, which leads to improvements in scientific innovation and laboratory informatics. This is likely to increase the demand in the market in the coming years.
Key Industry Players in the Global Drug Discovery and Development Solutions Market
The report gives a detailed analysis of the following key players in the global drug discovery and development solutions market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Abbott Laboratories Inc.
- AstraZeneca plc
- Genentech, USA Inc
- Charles River Laboratories International, Inc.
- Gilead Sciences, Inc.
- Pfizer Inc.
- Jubilant Biosys Ltd.
- Sanofi SA
- F. Hoffmann-La Roche Ltd
- Others
The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2016-2020 |
| Forecast Period | 2021-2026 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Service Type, Drug Type, Process, Technology, Mode, Therapeutic Area, End Use, Region |
| Breakup by Service Type | Medicinal Chemistry, Biology Services, Drug Metabolism, Pharmaceutical Services, Pharmacokinetics, Others |
| Breakup by Drug Type | Small Molecules, Biologics |
| Breakup by Process | Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimisation, Candidate Validation, Others |
| Breakup by Technology | High Throughput Screening, Biochips, Pharmacogenetics, Nanotechnology, Spectroscopy, Others |
| Breakup by Mode | In-house, Outsourced |
| Breakup by Therapeutic Area | Oncology, Neurology, Infectious and Immune System Diseases, Digestive System Diseases, Cardiovascular Diseases, Others |
| Breakup by End Use | Hospital & Clinics, Pharmaceutical Companies, Biotechnology Companies, Research Institute, Others |
| Breakup by Region | North America, Latin America, Europe, Middle East and Africa, Asia Pacific |
| Market Dynamics | SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Abbott Laboratories Inc., AstraZeneca plc, Genentech, USA Inc, Charles River Laboratories International, Inc., Gilead Sciences, Inc., Pfizer Inc., Jubilant Biosys Ltd., Sanofi SA, F. Hoffmann-La Roche Ltd, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Drug Discovery and Development Solutions Market Analysis
8.1 Key Industry Highlights
8.2 Global Drug Discovery and Development Solutions Historical Market (2016-2020)
8.3 Global Drug Discovery and Development Solutions Market Forecast (2021-2026)
8.4 Global Drug Discovery and Development Solutions Market by Service Type
8.4.1 Medicinal Chemistry
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2016-2020)
8.4.1.3 Forecast Trend (2021-2026)
8.4.2 Biology Services
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2016-2020)
8.4.2.3 Forecast Trend (2021-2026)
8.4.3 Drug Metabolism
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2016-2020)
8.4.3.3 Forecast Trend (2021-2026)
8.4.4 Pharmaceutical Services
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2016-2020)
8.4.4.3 Forecast Trend (2021-2026)
8.4.5 Pharmacokinetics
8.4.5.1 Market Share
8.4.5.2 Historical Trend (2016-2020)
8.4.5.3 Forecast Trend (2021-2026)
8.4.6 Others
8.5 Global Drug Discovery and Development Solutions Market by Drug Type
8.5.1 Small Molecules
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2016-2020)
8.5.1.3 Forecast Trend (2021-2026)
8.5.2 Biologics
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2016-2020)
8.5.2.3 Forecast Trend (2021-2026)
8.6 Global Drug Discovery and Development Solutions Market by Process
8.6.1 Target Selection
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2016-2020)
8.6.1.3 Forecast Trend (2021-2026)
8.6.2 Target Validation
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2016-2020)
8.6.2.3 Forecast Trend (2021-2026)
8.6.3 Hit-To-Lead Identification
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2016-2020)
8.6.3.3 Forecast Trend (2021-2026)
8.6.4 Lead Optimisation
8.6.4.1 Market Share
8.6.4.2 Historical Trend (2016-2020)
8.6.4.3 Forecast Trend (2021-2026)
8.6.5 Candidate Validation
8.6.5.1 Market Share
8.6.5.2 Historical Trend (2016-2020)
8.6.5.3 Forecast Trend (2021-2026)
8.6.6 Others
8.7 Global Drug Discovery and Development Solutions Market by Technology
8.7.1 High Throughput Screening
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2016-2020)
8.7.1.3 Forecast Trend (2021-2026)
8.7.2 Biochips
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2016-2020)
8.7.2.3 Forecast Trend (2021-2026)
8.7.3 Pharmacogenetics
8.7.3.1 Market Share
8.7.3.2 Historical Trend (2016-2020)
8.7.3.3 Forecast Trend (2021-2026)
8.7.4 Nanotechnology
8.7.4.1 Market Share
8.7.4.2 Historical Trend (2016-2020)
8.7.4.3 Forecast Trend (2021-2026)
8.7.5 Spectroscopy
8.7.5.1 Market Share
8.7.5.2 Historical Trend (2016-2020)
8.7.5.3 Forecast Trend (2021-2026)
8.7.6 Others
8.8 Global Drug Discovery and Development Solutions Market by Mode
8.8.1 In-house
8.8.1.1 Market Share
8.8.1.2 Historical Trend (2016-2020)
8.8.1.3 Forecast Trend (2021-2026)
8.8.2 Outsourced
8.8.2.1 Market Share
8.8.2.2 Historical Trend (2016-2020)
8.8.2.3 Forecast Trend (2021-2026)
8.9 Global Drug Discovery and Development Solutions Market by Therapeutic Area
8.9.1 Oncology
8.9.1.1 Market Share
8.9.1.2 Historical Trend (2016-2020)
8.9.1.3 Forecast Trend (2021-2026)
8.9.2 Neurology
8.9.2.1 Market Share
8.9.2.2 Historical Trend (2016-2020)
8.9.2.3 Forecast Trend (2021-2026)
8.9.3 Infectious and Immune System Diseases
8.9.3.1 Market Share
8.9.3.2 Historical Trend (2016-2020)
8.9.3.3 Forecast Trend (2021-2026)
8.9.4 Digestive System Diseases
8.9.4.1 Market Share
8.9.4.2 Historical Trend (2016-2020)
8.9.4.3 Forecast Trend (2021-2026)
8.9.5 Cardiovascular Diseases
8.9.5.1 Market Share
8.9.5.2 Historical Trend (2016-2020)
8.9.5.3 Forecast Trend (2021-2026)
8.9.6 Others
8.10 Global Drug Discovery and Development Solutions Market by End Use
8.10.1 Hospital & Clinics
8.10.1.1 Market Share
8.10.1.2 Historical Trend (2016-2020)
8.10.1.3 Forecast Trend (2021-2026)
8.10.2 Pharmaceutical Companies
8.10.2.1 Market Share
8.10.2.2 Historical Trend (2016-2020)
8.10.2.3 Forecast Trend (2021-2026)
8.10.3 Biotechnology Companies
8.10.3.1 Market Share
8.10.3.2 Historical Trend (2016-2020)
8.10.3.3 Forecast Trend (2021-2026)
8.10.4 Research Institute
8.10.4.1 Market Share
8.10.4.2 Historical Trend (2016-2020)
8.10.4.3 Forecast Trend (2021-2026)
8.10.5 Others
8.11 Global Drug Discovery and Development Solutions Market by Region
8.11.1 Market Share
8.11.1.1 North America
8.11.1.2 Europe
8.11.1.3 Asia Pacific
8.11.1.4 Latin America
8.11.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2016-2020)
9.1.2 Forecast Trend (2021-2026)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2016-2020)
9.2.2 Forecast Trend (2021-2026)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2016-2020)
9.3.2 Forecast Trend (2021-2026)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2016-2020)
9.4.2 Forecast Trend (2021-2026)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2016-2020)
9.5.2 Forecast Trend (2021-2026)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 EMR’s Key Indicators for Demand
10.4 EMR’s Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Abbott Laboratories Inc.
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 AstraZeneca plc
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Genentech, USA Inc
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Charles River Laboratories International, Inc.
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Gilead Sciences, Inc.
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 Pfizer Inc.
12.2.6.1 Company Overview
12.2.6.2 Product Portfolio
12.2.6.3 Demographic Reach and Achievements
12.2.6.4 Certifications
12.2.7 Jubilant Biosys Ltd.
12.2.7.1 Company Overview
12.2.7.2 Product Portfolio
12.2.7.3 Demographic Reach and Achievements
12.2.7.4 Certifications
12.2.8 Sanofi SA
12.2.8.1 Company Overview
12.2.8.2 Product Portfolio
12.2.8.3 Demographic Reach and Achievements
12.2.8.4 Certifications
12.2.9 F. Hoffmann-La Roche Ltd
12.2.9.1 Company Overview
12.2.9.2 Product Portfolio
12.2.9.3 Demographic Reach and Achievements
12.2.9.4 Certifications
12.2.10 Others
13 Industry Events and Developments
1. Global Drug Discovery and Development Solutions Market: Key Industry Highlights, 2016 and 2026
2. Global Drug Discovery and Development Solutions Historical Market: Breakup by Service Type (USD Billion), 2016-2020
3. Global Drug Discovery and Development Solutions Market Forecast: Breakup by Service Type (USD Billion), 2021-2026
4. Global Drug Discovery and Development Solutions Historical Market: Breakup by Drug Type (USD Billion), 2016-2020
5. Global Drug Discovery and Development Solutions Market Forecast: Breakup by Drug Type (USD Billion), 2021-2026
6. Global Drug Discovery and Development Solutions Historical Market: Breakup by Process (USD Billion), 2016-2020
7. Global Drug Discovery and Development Solutions Market Forecast: Breakup by Process (USD Billion), 2021-2026
8. Global Drug Discovery and Development Solutions Historical Market: Breakup by Technology (USD Billion), 2016-2020
9. Global Drug Discovery and Development Solutions Market Forecast: Breakup by Technology (USD Billion), 2021-2026
10. Global Drug Discovery and Development Solutions Historical Market: Breakup by Mode (USD Billion), 2016-2020
11. Global Drug Discovery and Development Solutions Market Forecast: Breakup by Mode (USD Billion), 2021-2026
12. Global Drug Discovery and Development Solutions Historical Market: Breakup by Therapeutical Area (USD Billion), 2016-2020
13. Global Drug Discovery and Development Solutions Market Forecast: Breakup by Therapeutical Area (USD Billion), 2021-2026
14. Global Drug Discovery and Development Solutions Historical Market: Breakup by End Use (USD Billion), 2016-2020
15. Global Drug Discovery and Development Solutions Market Forecast: Breakup by End Use (USD Billion), 2021-2026
16. Global Drug Discovery and Development Solutions Historical Market: Breakup by Region (USD Billion), 2016-2020
17. Global Drug Discovery and Development Solutions Market Forecast: Breakup by Region (USD Billion), 2021-2026
18. North America Drug Discovery and Development Solutions Historical Market: Breakup by Country (USD Billion), 2016-2020
19. North America l Drug Discovery and Development Solutions Market Forecast: Breakup by Country (USD Billion), 2021-2026
20. Europe Drug Discovery and Development Solutions Historical Market: Breakup by Country (USD Billion), 2016-2020
21. Europe Drug Discovery and Development Solutions Market Forecast: Breakup by Country (USD Billion), 2021-2026
22. Asia Pacific Drug Discovery and Development Solutions Historical Market: Breakup by Country (USD Billion), 2016-2020
23. Asia Pacific Drug Discovery and Development Solutions Market Forecast: Breakup by Country (USD Billion), 2021-2026
24. Latin America Drug Discovery and Development Solutions Historical Market: Breakup by Country (USD Billion), 2016-2020
25. Latin America Drug Discovery and Development Solutions Market Forecast: Breakup by Country (USD Billion), 2021-2026
26. Middle East and Africa Drug Discovery and Development Solutions Historical Market: Breakup by Country (USD Billion), 2016-2020
27. Middle East and Africa Drug Discovery and Development Solutions Market Forecast: Breakup by Country (USD Billion), 2021-2026
28. Global Drug Discovery and Development Solutions Market Structure
Key Questions Answered in the Report
The global drug discovery and development solutions market is projected to grow at a CAGR of 13% between 2021 and 2026.
The growth of the market is being driven by growing population, rising healthcare sector, increasing disposable incomes, growing R&D activities, and the rising pharmaceuticals sector.
The increasing focus on discovering medicines for the treatment of COVID-19 is an important industry trend guiding the growth of the market.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The leading service types in the market are medicinal chemistry, biology services, drug metabolism, pharmaceutical services, and pharmacokinetics, among others.
The major drug types in the industry are small molecules and biologics.
The significant process types in the market are target selection, target validation, hit-to-lead identification, lead optimisation, and candidate validation, among others.
The leading technology types in the industry are high throughput screening, biochips, pharmacogenetics, nanotechnology, and spectroscopy, among others.
The major therapeutic areas in the market are oncology, neurology, infectious and immune system diseases, digestive system diseases, and cardiovascular diseases, among others.
The major players in the industry are Abbott Laboratories Inc., AstraZeneca plc, Genentech, USA Inc, Charles River Laboratories International, Inc., Gilead Sciences, Inc., Pfizer Inc., Jubilant Biosys Ltd., Sanofi SA, and F. Hoffmann-La Roche Ltd, among others.
Analyst Review
The global drug discovery and development solutions market is being driven by the rising healthcare sector. Aided by the growing R&D activities, the market is expected to witness a robust growth in the forecast period of 2021-2026, growing at a CAGR of 13%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on service types, the market is segmented into medicinal chemistry, biology services, drug metabolism, pharmaceutical services, and pharmacokinetics, among others. On the basis of drug type, the industry is bifurcated into small molecules and biologics. By process types, the market is categorised into target selection, target validation, hit-to-lead identification, lead optimisation, and candidate validation, among others. Based on technology type, the industry is segmented into high throughput screening, biochips, pharmacogenetics, nanotechnology, and spectroscopy, among others. On the basis of therapeutic area, the market is divided into oncology, neurology, infectious and immune system diseases, digestive system diseases, and cardiovascular diseases, among others. The major regional markets for drug discovery and development solutions are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Abbott Laboratories Inc., AstraZeneca plc, Genentech, USA Inc, Charles River Laboratories International, Inc., Gilead Sciences, Inc., Pfizer Inc., Jubilant Biosys Ltd., Sanofi SA, and F. Hoffmann-La Roche Ltd, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global antifungal drugs market stood at a value of around USD 13.2 billion in 2020. The market is further expected to grow in the forecast period of 2021-2026 at a CAGR of 5% to reach USD 18.8 bil...
The global cough syrup market attained a value of nearly USD 5,572 million in 2020, driven by the increasing cases of respiratory disorders and rising geriatric population. Aided by growing government...
The global neutropenia treatment market attained a value of about USD 13.4 billion in 2020, driven by the rise in cancer cases leading to development of novel therapies. Aided by the rising awareness ...
The United States vaccine market attained a value of nearly USD 11.2 billion in 2020, driven by the rising use of mRNA technology in vaccine development. Aided by advancements in biotechnology and gen...
The global immunomodulators market attained an approximate value of USD 175 billion in 2020, driven by the rising prevalence of awareness among the masses regarding immunomodulators. Aided by the risi...
NEWSLETTER